Clinical Trial Update: Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 haploidentical stem cell transplantation strategy using early adoptive transfer of CD56+CD3- natural killer cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Acute Myeloid Leukemias, Advanced Hematological Malignancies | Phase 1, Phase 2 | Status: UNKNOWN